|
1
|
Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz
DP, Goldstein J, Nelson PS, Desprez PY and Campisi J:
Senescence-associated secretory phenotypes reveal
cell-nonautonomous functions of oncogenic RAS and the p53 tumor
suppressor. PLoS Biol. 6:2853–2868. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuilman T, Michaloglou C, Vredeveld LC,
Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ and Peeper DS:
Oncogene-induced senescence relayed by an interleukin-dependent
inflammatory network. Cell. 133:1019–1031. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coppé JP, Desprez PY, Krtolica A and
Campisi J: The senescence-associated secretory phenotype: The dark
side of tumor suppression. Ann Rev Pathol. 5:99–118. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang G, Rosen DG, Zhang Z, Bast RC Jr,
Mills GB, Colacino JA, Mercado-Uribe I and Liu J: The chemokine
growth-regulated oncogene 1 (Gro-1) links RAS signaling to the
senescence of stromal fibroblasts and ovarian tumorigenesis. Proc
Natl Acad Sci USA. 103:16472–16477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Serrano M and Blasco MA: Putting the
stress on senescence. Curr Opin Cell Biol. 13:748–753. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inomata K, Aoto T, Binh NT, Okamoto N,
Tanimura S, Wakayama T, Iseki S, Hara E, Masunaga T, Shimizu H and
Nishimura EK: Genotoxic stress abrogates renewal of melanocyte stem
cells by triggering their differentiation. Cell. 137:1088–1099.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Serrano M, Lin AW, McCurrach ME, Beach D
and Lowe SW: Oncogenic ras provokes premature cell senescence
associated with accumulation of p53 and p16INK4a. Cell. 88:593–602.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Collado M, Blasco MA and Serrano M:
Cellular senescence in cancer and aging. Cell. 130:223–233. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Childs BG, Durik M, Baker DJ and van
Deursen JM: Cellular senescence in aging and age-related disease:
From mechanisms to therapy. Nat Med. 21:1424–1435. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Isohata N, Aoyagi K, Mabuchi T, Daiko H,
Fukaya M, Ohta H, Ogawa K, Yoshida T and Sasaki H: Hedgehog and
epithelial-mesenchymal transition signaling in normal and malignant
epithelial cells of the esophagus. Int J Cancer. 125:1212–1221.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thiery JP, Acloque H, Huang RYJ and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okamoto K, Tajima H, Nakanuma S, Sakai S,
Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara
H, et al: Angiotensin II enhances epithelial-to-mesenchymal
transition through the interaction between activated hepatic
stellate cells and the stromal cell-derived factor-1/CXCR4 axis in
intrahepatic cholangiocarcinoma. Int J Oncol. 41:573–582. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laberge RM, Awad P, Campisi J and Desprez
PY: Epithelial-mesenchymal transition induced by senescent
fibroblasts. Cancer Microenviron. 5:39–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Velarde MC, Demaria M and Campisi J:
Senescent cells and their secretory phenotype as targets for cancer
therapy. Interdiscip Top Gerontol. 38:17–27. 2013.PubMed/NCBI
|
|
16
|
Moiseeva O, Deschênes-Simard X, St-Germain
E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak MN and Ferbeyre
G: Metformin inhibits the senescence-associated secretory phenotype
by interfering with IKK/NF-κB activation. Aging Cell. 12:489–498.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Makita N, Ninomiya I, Tsukada T, Okamoto
K, Harada S, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H,
et al: Inhibitory effects of valproic acid in DNA double-strand
break repair after irradiation in esophageal squamous carcinoma
cells. Oncol Rep. 34:1185–1192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Acosta JC, O'Loghlen A, Banito A, Guijarro
MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N,
et al: Chemokine signaling via the CXCR2 receptor reinforces
senescence. Cell. 133:1006–1018. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hernandez-Segura A, Brandenburg S and
Demaria M: Induction and validation of cellular senescence in
primary human cells. J Vis Exp. 2018:e577822018.PubMed/NCBI
|
|
20
|
Yi G, He Z, Zhou X, Xian L, Yuan T, Jia X,
Hong J, He L and Liu J: Low concentration of metformin induces a
p53-dependent senescence in hepatoma cells via activation of the
AMPK pathway. Int J Oncol. 43:1503–1510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hellweg CE, Spitta LF, Koch K, Chishti AA,
Henschenmacher B, Diegeler S, Konda B, Feles S, Schmitz C, Berger T
and Baumstark-Khan C: The role of the nuclear factor κB pathway in
the cellular response to low and high linear energy transfer
radiation. Int J Mol Sci. 19:22202018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Johmura Y, Sun J, Kitagawa K, Nakanishi K,
Kuno T, Naiki-Ito A, Sawada Y, Miyamoto T, Okabe A, Aburatani H, et
al: SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and
regulates senescence. Nat Commun. 7:105742016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zakikhani M, Dowling R, Fantus IG,
Sonenberg N and Pollak M: Metformin is an AMP kinase-dependent
growth inhibitor for breast cancer cells. Cancer Res.
66:10269–10273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ben Sahra I, Laurent K, Loubat A,
Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le
Marchand-Brustel Y and Bost F: The antidiabetic drug metformin
exerts an antitumoral effect in vitro and in vivo through a
decrease of cyclin D1 level. Oncogene. 27:3576–3586. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagano T, Nakano M, Nakashima A, Onishi K,
Yamao S, Enari M, Kikkawa U and Kamada S: Identification of
cellular senescence-specific genes by comparative transcriptomics.
Sci Rep. 6:317582016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ezure T, Sugahara M and Amano S: Senescent
dermal fibroblasts negatively influence fibroblast extracellular
matrix-related gene expression partly via secretion of complement
factor D. Biofactors. 45:556–562. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chun TH, Sabeh F, Ota I, Murphy H,
McDonagh KT, Holmbeck K, Birkedal-Hansen H, Allen ED and Weiss SJ:
MT1-MMP-dependent neovessel formation within the confines of the
three-dimensional extracellular matrix. J Cell Biol. 167:757–767.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takino T, Yoshimoto T, Nakada M, Li Z,
Domoto T, Kawashiri S and Sato H: Membrane-type 1 matrix
metalloproteinase regulates fibronectin assembly and N-cadherin
adhesion. Biochem Biophys Res Commun. 450:1016–1020. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakayama A, Ninomiya I, Harada S, Tsukada
T, Okamoto K, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi
H, et al: Metformin inhibits the radiation-induced invasive
phenotype of esophageal squamous cell carcinoma. Int J Oncol.
49:1890–1898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gonzalez-Angulo AM and Meric-Bernstam F:
Metformin: A therapeutic opportunity in breast cancer. Clin Cancer
Res. 16:1695–1700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee SY, Moon SJ, Kim EK, Seo HB, Yang EJ,
Son HJ, Kim JK, Min JK, Park SH and Cho ML: Metformin suppresses
systemic autoimmunity in roquinsan/san mice through
inhibiting b cell differentiation into plasma cells via regulation
of AMPK/mTOR/STAT3. J Immunol. 198:2661–2670. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Algire C, Moiseeva O, Deschênes-Simard X,
Amrein L, Petruccelli L, Birman E, Viollet B, Ferbeyre G and Pollak
MN: Metformin reduces endogenous reactive oxygen species and
associated DNA damage. Cancer Prev Res (Phila). 5:536–543. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Formentini L, Sánchez-Aragó M,
Sánchez-Cenizo L and Cuezva JM: The mitochondrial ATPase inhibitory
factor 1 triggers a ROS-mediated retrograde prosurvival and
proliferative response. Mol Cell. 45:731–742. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schreck R, Rieber P and Baeuerle PA:
Reactive oxygen intermediates as apparently widely used messengers
in the activation of the NF-kappa B transcription factor and HIV-1.
EMBO J. 10:2247–2258. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chien Y, Scuoppo C, Wang X, Fang X,
Balgley B, Bolden JE, Premsrirut P, Luo W, Chicas A, Lee CS, et al:
Control of the senescence-associated secretory phenotype by NF-κB
promotes senescence and enhances chemosensitivity. Genes Dev.
25:2125–2136. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Laberge RM, Sun Y, Orjalo AV, Patil CK,
Freund A, Zhou L, Curran SC, Davalos AR, Wilson-Edell KA, Liu S, et
al: MTOR regulates the pro-tumorigenic senescence-associated
secretory phenotype by promoting IL1A translation. Nat Cell Biol.
17:1049–1061. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Orjalo AV, Bhaumik D, Gengler BK, Scott GK
and Campisi J: Cell surface-bound IL-1alpha is an upstream
regulator of the senescence-associated IL-6/IL-8 cytokine network.
Proc Natl Acad Sci USA. 106:17031–17036. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Acosta JC, Banito A, Wuestefeld T,
Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka
F, Andrulis M, et al: A complex secretory program orchestrated by
the inflammasome controls paracrine senescence. Nat Cell Biol.
15:978–990. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Evans JMM, Donnelly LA, Emslie-Smith AM,
Alessi DR and Morris AD: Metformin and reduced risk of cancer in
diabetic patients. BMJ. 330:1304–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiralerspong S, Palla SL, Giordano SH,
Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi
GN and Gonzalez-Angulo AM: Metformin and pathologic complete
responses to neoadjuvant chemotherapy in diabetic patients with
breast cancer. J Clin Oncol. 27:3297–3302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Coyle C, Cafferty FH, Vale C and Langley
RE: Metformin as an adjuvant treatment for cancer: A systematic
review and meta-analysis. Ann Oncol. 27:2184–2195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wan G, Sun X, Li F, Wang X, Li C, Li H, Yu
X and Cao F: Survival benefit of metformin adjuvant treatment for
pancreatic cancer patients: A systematic review and meta-analysis.
Cell Physiol Biochem. 49:837–847. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dowling RJ, Niraula S, Stambolic V and
Goodwin PJ: Metformin in cancer: Translational challenges. J Mol
Endocrinol. 48:R31–R43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang JW, Zhang D, Yin HS, Zhang H, Hong
KQ, Yuan JP and Yu BP: Fusobacterium nucleatum promotes esophageal
squamous cell carcinoma progression and chemoresistance by
enhancing the secretion of chemotherapy-induced
senescence-associated secretory phenotype via activation of DNA
damage response pathway. Gut Microbes. 15:21978362023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang P, Lv C, Zhang T, Liu J, Yang J, Guan
F and Hong T: FOXQ1 regulates senescence-associated inflammation
via activation of SIRT1 expression. Cell Death Dis. 8:e29462017.
View Article : Google Scholar : PubMed/NCBI
|
